TY  - GEN 
AU  - Palau, P.
AU  - Seller, J.
AU  - Dominguez, E.
AU  - Gómez Otero, María Inés
AU  - Ramon, J. M.
AU  - Sastre, C.
AU  - de la Espriella, R.
AU  - Santas, E.
AU  - Minana, G.
AU  - Chorro, F. J.
AU  - González Juanatey, José Ramón
AU  - Nunez, J.
PY  - 2020
SN  - 0160-9289
UR  - http://hdl.handle.net/20.500.11940/16677
AB  - BACKGROUND: The pathophysiology of heart failure with preserved ejection fraction (HFpEF) is complex and multifactorial. Chronotropic incompetence (ChI) has emerged as a crucial pathophysiological mechanism. Beta-blockers, drugs with negative...
KW  - Ventricular Function
KW  - Humans
KW  - Adrenergic beta-Antagonists
KW  - Multicenter Studies as Topic
KW  - Prospective Studies
KW  - Benzodiazepines
KW  - Stroke Volume
KW  - Randomized Controlled Trials as Topic
KW  - Research Design
KW  - Heart Failure
TI  - Beta-blockers withdrawal in patients with heart failure with preserved ejection fraction and chronotropic incompetence: Effect on functional capacity rationale and study design of a prospective, randomized, controlled trial (The Preserve-HR trial)
DO  - 10.1002/clc.23345
KW  - CHUS
VL  - 43
ER  -